1H3.SI - Clearbridge Health Limited

SES - SES Delayed Price. Currency in SGD
Currency in SGD

Valuation measures4

Market cap (intra-day) 19.78M
Enterprise value 17.72M
Trailing P/E N/A
Forward P/E 0.16
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)0.52
Price/book (mrq)0.45
Enterprise value/revenue 0.47
Enterprise value/EBITDA -1.26

Trading information

Stock price history

Beta (5Y monthly) 0.72
52-week change 3-65.79%
S&P500 52-week change 33.90%
52-week high 30.0840
52-week low 30.0260
50-day moving average 30.0296
200-day moving average 30.0362

Share statistics

Avg vol (3-month) 31.26M
Avg vol (10-day) 3692.33k
Shares outstanding 5619.05M
Implied shares outstanding 6N/A
Float 8381.76M
% held by insiders 146.04%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Dec 2022


Profit margin -67.90%
Operating margin (ttm)-7.52%

Management effectiveness

Return on assets (ttm)-1.10%
Return on equity (ttm)-17.68%

Income statement

Revenue (ttm)16.41M
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)9.58M
Net income avi to common (ttm)-10.16M
Diluted EPS (ttm)-0.0300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)6.05M
Total cash per share (mrq)0.01
Total debt (mrq)7.47M
Total debt/equity (mrq)16.35
Current ratio (mrq)2.12
Book value per share (mrq)0.07

Cash flow statement

Operating cash flow (ttm)-1.98M
Levered free cash flow (ttm)5M